Mini Review - (2024) Volume 12, Issue 1
Received: 01-Jan-2024, Manuscript No. JCMG-24-129844;
Editor assigned: 03-Jan-2024, Pre QC No. P-129844;
Reviewed: 17-Jan-2024, QC No. Q-129844;
Revised: 23-Jan-2024, Manuscript No. R-129844;
Published:
30-Jan-2024
, DOI: 10.37421/2472-128X.2024.12.264
Citation: Carlie, Myles. “Integration of Glutamate Dehydrogenase
and Nanoporous Gold for Electrochemical Detection of Glutamate.” J Clin Med
Genomics 12 (2024): 264.
Copyright: © 2024 Carlie M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Glutamate is a crucial neurotransmitter in the central nervous system, playing a pivotal role in various physiological processes. Accurate detection of glutamate levels is essential for understanding its role in health and disease. Electrochemical detection methods have gained significant attention due to their sensitivity, selectivity, and rapid response. This article reviews the integration of Glutamate Dehydrogenase (GDH) and Nano porous Gold (NPG) for electrochemical detection of glutamate. GDH serves as a biorecognition element, facilitating selective glutamate detection, while NPG offers a high surface area and excellent conductivity for enhancing sensitivity. This review discusses the principles, recent advancements, challenges, and future prospects of this integrated approach for glutamate detection.
Electrochemical detection • Glutamate detection • Bio recognition element
Glutamate, an excitatory neurotransmitter in the central nervous system, is involved in various physiological processes such as learning, memory, and synaptic plasticity. Dysregulation of glutamate levels has been implicated in neurological disorders like Alzheimer's disease, Parkinson's disease, and epilepsy. Thus, accurate and sensitive detection of glutamate is essential for understanding its role in health and disease. Electrochemical detection methods offer several advantages over traditional analytical techniques, including high sensitivity, selectivity, rapid response, and compatibility with miniaturized devices for point-of-care applications. Integrating Glutamate Dehydrogenase (GDH) with Nanoporous Gold (NPG) has emerged as a promising approach for electrochemical detection of glutamate [1-3].
Principles of glutamate detection: GDH is an enzyme that catalyzes the oxidative deamination of glutamate to α-ketoglutarate and ammonia, using NADH+ as a cofactor. This reaction can be monitored electrochemically by measuring the consumption or production of NADH, which is directly proportional to the glutamate concentration. The immobilization of GDH onto a transducer surface allows for specific and selective detection of glutamate in complex biological samples. NPG, a three-dimensional nanostructured material composed of interconnected gold nanoparticles, possesses unique properties such as high surface area, excellent electrical conductivity, and biocompatibility. These characteristics make NPG an ideal candidate for enhancing the sensitivity and performance of electrochemical biosensors [4].
Integration of GDH and NPG: The integration of GDH and NPG involves immobilizing GDH onto the surface of NPG-modified electrodes. This can be achieved through various techniques such as physical adsorption, covalent binding, or entrapment within a polymer matrix. The immobilized GDH retains its enzymatic activity and selectively catalyzes the oxidation of glutamate in the presence of other interfering species. The NPG-modified electrode provides an efficient platform for electron transfer between the enzyme and the electrode surface, resulting in enhanced sensitivity and electrochemical performance. The high surface area of NPG facilitates greater enzyme loading and provides a larger interface for glutamate detection, leading to improved analytical performance.
Recent advancements: Recent advancements in the integration of GDH and NPG for glutamate detection have focused on optimizing the immobilization techniques, exploring novel electrode architectures, and enhancing the overall sensor performance. Strategies such as enzyme encapsulation, surface functionalization, and nanomaterial composites have been employed to improve the stability, selectivity, and sensitivity of the biosensors. Furthermore, the development of miniaturized and portable electrochemical platforms has enabled real-time monitoring of glutamate levels in biological fluids, offering potential applications in clinical diagnosis, neuroscience research, and therapeutic monitoring. Additionally, the integration of microfluidic systems with GDH/NPG-based biosensors allows for automated sample handling and high-throughput analysis, further enhancing their utility in various biomedical applications.
Challenges and future prospects: Despite significant progress, several challenges remain in the development and implementation of GDH/NPG-based biosensors for glutamate detection. These include optimizing the enzyme immobilization process, improving the sensor stability and reproducibility, minimizing interference from other analytes, and enhancing the selectivity towards glutamate. Future research directions may focus on exploring novel immobilization strategies, such as enzyme Nano carriers and molecular imprinting techniques, to enhance the stability and selectivity of GDH/NPG-based biosensors. Moreover, the integration of signal amplification strategies, such as nanomaterial-based signal amplifiers and electrocatalysts, could further improve the sensitivity and detection limits of the biosensors [5,6].
The integration of GDH and NPG holds great promise for the development of highly sensitive and selective electrochemical biosensors for glutamate detection. By harnessing the synergistic properties of GDH and NPG, researchers can overcome existing challenges and pave the way for innovative biomedical applications in neuroscience, clinical diagnostics, and therapeutics. Continued advancements in this field are essential for realizing the full potential of GDH/NPG-based biosensors in improving our understanding of glutamate-related disorders and facilitating early disease diagnosis and treatment.
None.
None.
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Google Scholar, Crossref, Indexed at
Journal of Clinical & Medical Genomics received 391 citations as per Google Scholar report